Andrew R. Marks, M.D.

Andrew Robert Marks (born February 22, 1955), is an American cardiologist and molecular biologist. He is Professor and Chair of the Department of Physiology and Cellular Biophysics at Columbia University College of Physicians and Surgeons, Founding Director of the Clyde and Helen Wu Center for Molecular Cardiology,[1] and a Wu Professor of Medicine.

Marks developed the first drug-eluting stent coated with rapamycin in an effort to reduce fatty plaque buildup on the stent material itself.[2]

References

  1. ↑ "Andrew R. Marks, MD". columbia.edu. Columbia University. Retrieved 30 August 2016.
  2. ↑ "Andrew Marks". www.heart.org. 22 June 2010. Retrieved 21 September 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.